CORDIS
EU research results

CORDIS

English EN
A European Training Network to Combat  Bone Pain

A European Training Network to Combat Bone Pain

Objective

In Europe 20 - 30% of adults are affected at any one time by musculoskeletal pain such as arthritic pain, lower back pain, pain from osteoporotic fractures and bone metastasis, and also most rare bone diseases are very painful. Despite a huge negative impact on the quality of life of the patients and on society as a whole, no specific treatment is yet available. Therefore, there is a strong need to train highly skilled researchers within bone pain and thereby make the foundation for improved therapies. In this proposal we bring together 3 industrial beneficiaries, 8 academic beneficiaries, and one industrial partner all committed to train a new generation of 15 creative, entrepreneurial and innovative early stages researchers in bone pain research and transferable skills. The early stages researchers will train with some of the foremost neuroscientists and bone researchers in academia and industry across Europe. The BonePainII training network will provide the early stage researchers with expertise that will enable them to gain high level employment both in academia and industry. In a multidisciplinary, intersectoral and integrated project we will develop advanced 3D microfluidic in vitro platforms and high throughput techniques to investigate bone-neuron interactions; validate and investigate novel in vivo models of bone pain including a rare bone disease; and using cutting-edge technologies to identify key mechanisms underlying bone pain in osteoarthritis, rheumatoid arthritis, and cancer-induced bone pain.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

KOBENHAVNS UNIVERSITET

Address

Norregade 10
1165 Kobenhavn

Denmark

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 595 044

Participants (10)

Sort alphabetically

Sort by EU Contribution

Expand all

KING'S COLLEGE LONDON

United Kingdom

EU Contribution

€ 303 172,56

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 281 982,96

UNIVERSITY COLLEGE LONDON

United Kingdom

EU Contribution

€ 606 345,12

THE ROYAL VETERINARY COLLEGE

United Kingdom

EU Contribution

€ 303 172,56

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

Netherlands

EU Contribution

€ 531 239,76

NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN

Germany

EU Contribution

€ 252 788,40

INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA

Portugal

EU Contribution

€ 237 720,24

NORDIC BIOSCIENCE A/S

Denmark

EU Contribution

€ 595 044

ASTRAZENECA UK LIMITED

United Kingdom

EU Contribution

€ 303 172,56

CELLECTRICON AB

Sweden

EU Contribution

€ 281 982,96

Partners (1)

Sort alphabetically

Expand all

TRANSPHARMATION LTD

Project information

Grant agreement ID: 814244

Status

Ongoing project

  • Start date

    1 January 2019

  • End date

    31 December 2022

Funded under:

H2020-EU.1.3.1.

  • Overall budget:

    € 4 291 665,12

  • EU contribution

    € 4 291 665,12

Coordinated by:

KOBENHAVNS UNIVERSITET

Denmark